Travere Therapeutics
TVTX
$5.68
Share price
4.03%
Change (1 day)
-74.88%
Change (1 year)
Categories
Operating Margin for Travere Therapeutics (TVTX)
Operating Margin as of April 2024 (TTM): -130.82%
According to Travere Therapeutics's latest financial reports and stock price the company's current Operating Margin is -130.82%. At the end of 2021 the company had an Operating Margin of -70.13%.
Operating Margin history for Travere Therapeutics from 2014 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -70.13% | -18.06% |
| 2020 | -85.59% | 17.59% |
| 2019 | -72.79% | 29.86% |
| 2018 | -56.05% | 51.88% |
| 2017 | -36.90% | 23.77% |
| 2016 | -29.82% | -7.68% |
| 2015 | -32.29% | -88.59% |
| 2014 | -282.97% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -72.21% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 6,314.27% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.